Clinical Trials Directory

Trials / Completed

CompletedNCT03601221

Seroprevalence Hepatitis E Infection in Healthy Blood Donors

Observational Study on Seroprevalence of Hepatitis E Infection in Healthy Blood Donors in the Canton Ticino

Status
Completed
Phase
Study type
Observational
Enrollment
1,447 (actual)
Sponsor
Ente Ospedaliero Cantonale, Bellinzona · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

This is a HEV seroprevalence in the health donors in the Canton Ticino study. The pre-donation sampling pouch of each blood donor coming form the Cantone Ticino region will be collected and tested for HEV serology (IgM and IgG).

Detailed description

Pre-donation sampling pouch of fresh and stored frozen plasma collected within the last 5 years will be tested for HEV IgG serology at the National Reference Laboratory of the Blood Transfusion Services SRC in Berne Collected data will be used to determine HEV seroprevalence, actual and in the last 5 years, in the Canton Ticino and to investigate trend and pattern of the HEV infection (seroprevalence by different regional areas, comparison with national HEV data, and correlation with age, sex and place of residence).

Conditions

Interventions

TypeNameDescription
OTHERSample collectionCollection of one sampling pouch from each blood donor

Timeline

Start date
2018-05-29
Primary completion
2018-12-31
Completion
2019-12-31
First posted
2018-07-26
Last updated
2020-03-31

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03601221. Inclusion in this directory is not an endorsement.